Advancing Access to HIV/HCV Testing for People Who Inject Drugs (PWID) (ACCESS)

University of Miami

Status: Enrolling

Conditions: HIV Infections

Treatments: Behavioral: ACCESS Intervention; Behavioral: Control Group

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT06730555

20240611

R01DA060462 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to test the effectiveness of the ACCESS strategy: an organizational-level intervention that uses funding and practice facilitation to improve the organizational capacity of syringe services programs (SSPs) to implement routine, opt-out HIV and Hepatitis C (HCV) testing and linkage to care for people who inject drugs (PWID).

Enrollment: 40 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• SSPs must:

  1. be operating in an Ending the HIV Epidemic (EHE) or Centers for Disease Control and Prevention (CDC) determined vulnerable jurisdictions;
  2. serve at least 300 unique participants per year;
  3. not currently offer opt-out HIV/HCV testing;
  4. be capable and willing to prospectively collect aggregated, site-level data on the number of participants who are: i) offered HIV/HCV screening, ii) completed these tests, and iii) linked to care, as well as provide participant demographics;
  5. have key staff that consent to participate in study surveys, qualitative interviews and practice facilitation throughout the study.

Exclusion criteria

• SSPs must not:

  1. currently receive or have received Frontline Communities in the United States (FOCUS) funding;
  2. have already implemented opt-out HIV/HCV testing.
  3. currently participating in SAIA-SSP-HIV (NCT06025435)

Trial design

Primary purpose: Screening

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

40 participants in 2 patient groups

ACCESS Group

Experimental group

Description:

Participants in this group will receive the ACCESS intervention for up to 18 months

Treatment:

Behavioral: ACCESS Intervention

Control Group

Active Comparator group

Description:

Participants in this group will receive a link to the CDC Compendium of Evidence-Based Interventions for up to 18 months.

Treatment:

Behavioral: Control Group